Delivery Order SPE2DR25D1202-SPE2DR26F73RG
Award Date 1/6/26
Potential Completion Date 1/7/26
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,862.33 for Actemra ActPen 162 mg/0.9 mL injectable medication, with an ultimate completion date of December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $19,985.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injectors. The order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. This delivery order was competitively awarded without...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,058.52 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL injectable medication. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this firm fixed-price contract requires performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,111.54 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The contract, which is a child delivery order under a larger indefinite delivery vehicle, was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will take place at...
- The Defense Logistics Agency (DLA) awarded a $7,842.98 delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. This non-set-aside, firm fixed price contract was executed on December 19, 2025, with completion scheduled for December 22, 2025. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,915.67 for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. The contract, issued on December 29, 2025, with an ultimate completion date of December 30, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This order is a child...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $19,218.06 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector pharmaceutical product. The contract carries a ceiling value of $39,585.79 with firm fixed pricing and is scheduled for ultimate completion on November 18, 2025. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $15,720.54 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This firm fixed-price delivery order, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a Delivery Order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Actemra ActPen 162 mg/0.9 ml auto-injectors with a ceiling value of $8,352.14. This is a firm fixed-price order with an ultimate completion date of December 1, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing indefinite delivery contract (IDC) vehicle. The place of performance is AmerisourceBergen's corporate office location in...